This is a sel -a chi ed e sion o an o iginal a icle. This e sion
may di e om he o iginal in pagina ion and ypog aphic de ails.
Au ho (s):
Ti le:
Yea :
Ve sion:
Copy igh :
Righ s:
Righ s u l:
Please ci e he o iginal e sion:
CC BY-NC 4.0
h ps://c ea i ecommons.o g/licenses/by-nc/4.0/
Cu(ii)- hiophene-2,5-bis(amino-alcohol) media ed asymme ic Aldol eac ion and
Domino Knoe enagel Michael cycliza ion : a new highly e icien Lewis acid ca alys
© 2022 he Au ho s
Published e sion
Al-Majid, Abdullah Mohammed; Alamma i, Abdullah Saleh; Alshah ani, Saeed;
Haukka, Ma i; Islam, Mohammad Shahidul; Ba aka , Assem
Al-Majid, A. M., Alamma i, A. S., Alshah ani, S., Haukka, M., Islam, M. S., & Ba aka , A. (2022).
Cu(ii)- hiophene-2,5-bis(amino-alcohol) media ed asymme ic Aldol eac ion and Domino
Knoe enagel Michael cycliza ion : a new highly e icien Lewis acid ca alys . RSC Ad ances,
12(10), 6149-6165. h ps://doi.o g/10.1039/d2 a00674j
2022
Cu(II)- hiophene-2,5-bis(amino-alcohol) media ed
asymme ic Aldol eac ion and Domino
Knoe enagel Michael cycliza ion: a new highly
efficien Lewis acid ca alys †
Abdullah Mohammed Al-Majid,*
a
Abdullah Saleh Alamma i,
a
Saeed Alshah ani,
a
Ma i Haukka,
b
Mohammad Shahidul Islam *
a
and Assem Ba aka
a
The highly efficien Lewis acid-ca aly ic sys em Cu(II)- hiophene-2,5-bis(amino-alcohol) has been
de eloped o enan ioselec i e Aldol eac ion o isa in de i a i es wi h ke ones. The new ca aly ic sys em
also p o ed o be highly enan ioselec i e o he one po h ee-componen Domino Knoe enagel
Michael cycliza ion eac ion o subs i u ed isa in wi h malononi ile and e hylace oace a e. The chi al
ligand (2S,20S)-2,20-(( hiophene-2,5-diylbis(me hylene))bis(azanediyl))bis(3-phenylp opan-1-ol) (L1)in
combina ion wi h Cu(OAc)
2
$H
2
O employed as a new Lewis acid ca alys , u nished 3-subs i u ed-3-
hyd oxyindolin-2-ones de i a i es (3a–s) in good o excellen yields (81–99%) wi h high
enan ioselec i i ies (up o 96% ee) and spi o[4H-py an-3,3-oxindole] de i a i es (6a–l) in excellen yields
(89–99%) wi h high ee (up o 95%). These aldol p oduc s and spi o-oxindoles cons i u e a co e s uc u al
mo i in a la ge numbe o pha maceu ically ac i e molecules and na u al p oduc s.
In oduc ion
The chi al ligand–Lewis acid–me al ca alysed ca bon–ca bon
bond cons uc ion p ocess has become inc easingly in e es ing
o syn he ic chemis s as well as pha macis s, o ca ying ou
a ious c ucial o ganic ans o ma ions. In pa icula , chi al
e sions o hese ca aly ic p ocesses a e one o he p ominen
s a egies o access se e al enan iopu e bioac i e molecules.
1–5
Among hem, he asymme ic Aldol eac ion and Domino
Knoe enagel Michael cycliza ion eac ion a e he mos powe ul
and efficien app oaches o accessing a ious enan iome ically
en iched biomolecules.
6,7
The co e amewo k ‘3-alkyl-3-hyd oxyindolin-2-ones’is
p esen in a la ge numbe o na u al p oduc s
8–14
and d ug
molecules
15–19
such as ma emycins,
17
a undaphine,
20
donaxa -
idine,
21
pa a unamide,
22
,(R)-con olu amydines A, B and E,
23–27
us aminol,
28
diazonamides,
29–33
lep osin D,
34
30-
hyd oxyglucoisa isin,
35
CPC-1,
36
3-hyd oxy welwi indolinones
C,
37
TMC-95 (A–D),
38–40
celogen in K,
41
dioxib assinin
42
(Fig. 1).
The e o e, he de elopmen o efficien and p ac ical
me hods o syn hesize his kind o building block is o g ea
impo ance and is cu en ly an open a ea o esea ch in asym-
me ic ca alysis.
43–45
A ep esen a i e example has been de el-
oped ecen ly o asymme ic Aldol eac ion o ke ones wi h
Fig. 1 P ominen bioac i e compounds based 3-subs i u ed-3-
hyd oxy-2-oxindoles and spi o[4H-py an-3,30-oxindole] mo i s.
a
Depa men o Chemis y, College o Science, King Saud Uni e si y, P. O. Box 2455,
Riyadh 11451, Saudi A abia. E-mail: 436106737@s uden .ksu.edu.sa;
[email p o ec ed]; [email p o ec ed]du.sa; chemis y99y@gmail.
com; [email p o ec ed].sa; [email p o ec ed]; [email p o ec ed]; Fax: +966-
61-1467-5992
b
Depa men o Chemis y, Uni e si y o Jy ¨
askyl¨
a, P. O. Box 35, FI-40014 Jy ¨
askyl¨
a,
Finland. E-mail: ma i.o.haukka@jyu.
†Elec onic supplemen a y in o ma ion (ESI) a ailable. CCDC 2143162. Fo ESI
and c ys allog aphic da a in CIF o o he elec onic o ma see DOI:
10.1039/d2 a00674j
Ci e his: RSC Ad ., 2022, 12,6149
Recei ed 31s Janua y 2022
Accep ed 9 h Feb ua y 2022
DOI: 10.1039/d2 a00674j
sc.li/ sc-ad ances
© 2022 The Au ho (s). Published by he Royal Socie y o Chemis y RSC Ad .,2022,12,6149–6165 | 6149
RSC Ad ances
PAPER
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
View Jou nal
| View Issue
a ious isa ins which is one o he mos s aigh o wa d and
powe ul me hods in o de o achie e highly enan iopu e bio-
logically ac i e co e amewo k ‘3-alkyl-3-hyd oxyindolin-2-
ones’wi h new chi al s e eocen e s.
46–52
E e since, p oline
ca alysed c oss-Aldol eac ion o aldehydes and ke ones s
epo ed by Lis and Ba bas in 2000,
53
since hen, lo o chi al
amine ligands ha e been used as o gano-ca alys o he c oss-
Aldol asymme ic eac ion.
47,54
In 2005, o he s ime asym-
me ic Aldol eac ion o isa in wi h ace one was s de eloped
by Tomasini e al. employing dipep ide-based ligand as o ga-
noca alys .
55–59
Howe e , signican effo s ha e been made o
de eloping efficien asymme ic Aldol eac ions o isa ins wi h
ke ones mos ly using o ganoca alys s such as p oline,
60–62
p o-
linamides,
63–69
sulphonamides,
70–72
amines,
73,74
quinidine- hio-
u eas,
75–77
icinal amino-alcohol,
78
enzymes,
79
4-
hyd oxydia ylp olinol
80
and amino acid sal s.
81
The spi o-he e ocyclic oxindoles a e he eye-ca ching a ge s
o he syn he ic chemis and biologis because o hei biolog-
ical signicance o a wide- ange o syn he ic u ili y such as
alkaloids in e media es, d ug candida es and clinical pha ma-
ceu icals agen s.
82–89
In pa icula , ‘spi o[4H-py an-3,30-oxin-
dole]’moie y is he mos impo an he e ocyclic skele on ha
could be ound in spi ooxindoles amewo k complex mole-
cules o se e al alkaloids and d ug agen s.
82,83
O e he couple
yea s, sizable numbe o in es iga ion ha e been ca ied ou
success ully o he cons uc ion o spi o[4H-py an-3,30-oxin-
dole] amewo k as a co e skele on o spi ooxindole s uc-
u es.
90–92
Domino Knoe enagel Michael cycliza ion is one o he
highly success ul p ocedu es o he s e eoselec i e syn hesis o
spi ooxindole de i a i es de i ed spi o[4H-py an-3,30-oxindole]
moie y.
93,94
To cons uc his in e es ing scaffold, Yuan and co-
wo ke s in 2010 o he s ime, u ilized cup eine-(60-
hyd oxycinchonidine) as o ganoca alys o accessing chi al
spi o[4H-py an-3,30-oxindole] de i a i es om mul i compo-
nen eac ions o N-alkyla ed isa ins.
95
Recen ly, Nakano e al.
epo ed hyb id squa amide amino alcohol o gano-ca alyzed
asymme ic Domino Michael cycliza ion eac ions o oxoindo-
lines wi h cyclic 1,3-dike ones, affo ding chi al spi o-
conjuga ed oxindoles e he ing 2-aminopy ans he e ocyclic
ing sys ems wi h excellen yield and enan ioselec i i y.
96
In
2019, Swapna Konda and co-wo ke s syn hesized chi al spi o
[4H-py an-3,30-oxindole] de i a i es wi h good chemical yield
(up o 92%) and enan ioselec i i y (up o 87% ee) using
cinchona alkaloid hiou eas as an o ganoca alys s.
97
Howe e ,
ill da e e y limi ed effo s ha e been made o he cons uc ion
o s e eoselec i e spi o-he e ocyclic oxindole, eng aing 2-
amino-4H-py an-3-ca boni ile ing a he C
3
posi ion o oxin-
dole ia asymme ic Domino Michael cycliza ion eac ion.
Howe e , e y limi ed ndings ha e been epo ed o he
applica ion o Lewis acid ca alyzed asymme ic Aldol eac ion
98
o ke ones wi h isa in in o de o excess de i a i e o ‘3-alkyl-3-
hyd oxyindolin-2-ones’and asymme ic Domino Michael cycli-
za ion eac ion
99–101
o isa in wi h malononi ile and e hyl-
ace oace a e o u nish enan iopu e spi o[4H-py an-3,30-
oxindole] de i a i es. The e o e, u he in es iga ions a e
equi ed o p oduce bioac i e mo i like ‘3-alkyl-3-
hyd oxyindolin-2-ones’and spi o[4H-py an-3,30-oxindole] using
Lewis acid ca alys , ha emains a g ea challenge.
Recen ly, a se ies o new chi al bis(amino-alcohol) hiophene
ligands-Cu(OAc)
2
$H
2
O as a Lewis acid ca aly ic sys em ha e
been de eloped by ou g oup and hei ca aly ic applica ion was
success ully applied o enan ioselec i e Hen y eac ion o
affo d he co esponding chi al Hen y p oduc wi h sa is ac o y
yield and enan ioselec i i y.
5
On obse ing hei good ca aly ic
enan ioselec i e induc ion in he Hen y eac ion, we decided o
explo e he u ili y o hose chi al ligands o diffe en applica-
ions such as enan ioselec i e Aldol eac ion as well as Domino
Michael cycliza ion eac ion.
As pe he bes o ou knowledge, we a e epo ing o he
s ime chi al bis(amino-alcohol) hiophene ligand–Lewis acid
ca alysed enan ioselec i e Aldol eac ion o isa ins wi h
subs i u ed ace one o p oduce enan iopu e 3-subs i u ed-3-
hyd oxy-2-oxindoles de i a i es as well as Domino Michael
cycliza ion eac ion o isa ins wi h malononi ile and e hyl-
ace oace a e o affo d he chi al oxindoles spi o[4H-py an-3,30-
oxindole] used wi h 2-aminopy ans he e ocyclic ing sys ems.
Resul s and discussion
Ca aly ic asymme ic s udies o Aldol eac ion
The ollowing ligands as shown in Fig. 2 epo ed ecen ly by
ou esea ch g oup as an examples o C
2
-symme ic chi al
hiophene-2,5-bis(amino-alcohol) ligands (L1–L5) and success-
ully applied hem in ca aly ic asymme ic Hen y eac ion o
ni ome hane wi h subs i u ed aldehydes in excellen yield and
enan ioselec i i y (yield up o 99% and ee up o 95%).
5
(Fig. 2).
We u he decided o examine hei asymme ic ca aly ic effi-
ciency and he e o e enan ioselec i e Aldol eac ion o isa in
wi h subs i u ed ace one as well as h ee-componen chi al
Domino Michael cycliza ion eac ion o isa in wi h malononi-
ile and e hylace oace a e ha e been explo ed success ully.
Ini ially, Aldol eac ion o 5-b omoisa in (1a) wi h ace one
(2a) as model subs a e we e ca ied ou o accessing 3-
subs i u ed-3-hyd oxy-2-oxindoles de i a i es, using 20 mol%
chi al hiophene-2,5-bis(amino-alcohol) ligands (L1–L5)as
o ganoca alys s in e hanol (2 mL) a oom empe a u e ( )
unde ine a mosphe e o 24–48 h and we obse e ha , all he
ligands we e ound o be efficien o u nish aldol p oduc 3a
(89–99% yield) in excellen yield bu un o una ely ailed o
induce enan ioselec i i y (16–21% ee) effec i ely (Table 1).
Then he ca aly ic efficacy o hese ligands we e examined in
combina ion wi h me al sal like coppe ace a e monohyd a e
(Cu(OAc)
2
$H
2
O) gene a ed a me al complex in si u as a Lewis
Fig. 2 C
2
-symme ic chi al hiophene-2,5-bis(amino-alcohol) ligands
(L1–L5) used o Aldol eac ion and Domino Michael addi ion eac ion.
6150 |RSC Ad ., 2022, 12,6149–6165 © 2022 The Au ho (s). Published by he Royal Socie y o Chemis y
RSC Ad ances Pape
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
acid ca aly ic sys em o asymme ic Aldol eac ion o 5-b o-
moisa in (1a) wi h ace one (2a, 50 eq.). Subsequen ly, he eac-
ion was pe o med in e hanol (2 mL) a 25 C unde ine
a mosphe e, using 10 mol% o ligands L1–L5 wi h 20 mol% o
Cu(OAc)
2
$H
2
O o 24 h and he co esponding ndings we e
documen ed in Table 2. Fo una ely, all he ligands (L1–L5)
we e ound o be capable o p oducing aldol p oduc 3a wi h
signican ly enhanced enan ioselec i i y (44–58% ee) (Table 2,
en ies 1–5) bu he chemical yields we e signican ly d opped
(44–60%). In e es ingly, ligand L1 and L4 bea ing benzyl and -
bu yl g oup espec i ely we e ound o be he mos effec i e
ligand in combina ion wi h Cu(OAc)
2
$H
2
O, u nishing highes
yield (60% and 58%) acco dingly. Howe e , highe enan iose-
lec i i y (58% ee) was obse ed in p esence o L1 as compa ed o
L4 (48% ee) (Table 2, en ies 1 and 4) and he e o e L1 has been
chosen o u he op imiza ion.
In o de o imp o e he yield and enan ioselec i i y, asym-
me ic Aldol eac ion o 5-b omoisa in (1a) wi h ace one (2a,50
eq.) was u he in es iga ed. The effec o diffe en me al sal s
such as Cu(OAc)
2
$H
2
O, Zn(OAc)
2
$2H
2
O, Zn(OT )
2
, Mg(OT )
2
,
E (OT )
3
and Yb(OT )
3
as a Lewis acid as well as a ious sol en s
sys em like E OH, CH
2
Cl
2
, dioxane and THF we e explo ed,
using 10 mol% o ligand L1 wi h 20 mol% me al sal s a o e
he pe iod o 24–72 h and he summe y o he esul s we e
shown in Table 3. I is e iden om he esul s ha , he ca aly ic
sys em o L1-Cu(OAc)
2
$H
2
O in sol en s like CH
2
Cl
2
and
dioxane, imp o ed enan iome ic excess (ee) (74% & 76%)
espec i ely as compa ed o e hanol (yield 60%, ee 58%) bu he
chemical yields we e s ill low (58% and 45%) (Table 3, en ies 1–
3). Howe e , in case o ca aly ic sys em L1-Cu(OAc)
2
$H
2
O
(10 : 20 mol%) in THF as sol en was ound o be he bes choice
as Lewis acid ca alys o he asymme ic Aldol eac ion o 5-
b omoisa in (1a) wi h ace one (2a, 50 eq.), u nishing he bes
yield and enan ioselec i i y (65% yield, 82% ee) (Table 3, en y
4). Ne e heless, L1-Zn(OAc)
2
$2H
2
O in THF p oduce 50% yield
wi h e y poo enan ioselec i i y (17% ee) in 72 h (Table 3, en y
4). Mo eo e , ligand L1 in combina ion wi h me al sal s like
Zn(OT )
2
, Mg(OT )
2
, E (OT )
3
and Yb(OT )
3
in THF we e ound o
be comple ely ineffec i e o he asymme ic Aldol eac ion
(Table 3, en ies 6–9). The poo efficiency o Zn
+2
complex as
compa ed o Cu
+2
complex could be a ibu ed o he highe
elec onega i i y [EN o (Cu
2+
)¼1.90 > EN o (Zn
2+
)¼1.65] and
g ea e cha ge o adius a io o Cu
+2
han Zn
+2
ion, hose a e
wo ac o s pe haps help Cu
2+
o o m co alen bond wi h O
and N a oms o ligand s onge han Zn
2+
du ing he complex
o ma ion.
F om hese se e al a emp s o achie e accep able yield and
high enan ioselec i i y, i can be concluded ha , L1-Cu(OAc)
2
-
$H
2
O (10 : 20 mol%) as Lewis acid ca alys , in THF a o 24 h
Table 1 Enan ioselec i i y Aldol eac ion o 5-b omoisa in (1a) wi h
ace one (2a) ca alyzed by o ganoca alys s L1–L5
En ies
a
Ligands Time (h) Yield
b
(%) ee
c
(%)
1L1 24 99 21
2L2 24 99 16
3L3 24 99 19
4L4 24 99 20
5L5 48 89 20
a
Reac ions we e pe o med on 0.2 mmol o isa in and 10.0 mmol o
ace one.
b
Isola ed yields ae column pu ica ion.
c
Enan iome ic
excess (ee) was de e mined by chi al HPLC using a Daicel Chi alpak
AD-H (25 cm 4.6 mm 5mm).
Table 2 Enan ioselec i i y Aldol eac ion o 5-b omoisa in (1a) wi h
ace one (2a) ca alyzed by ligand (L1–L5) in p esence o Cu(OAc)
2
$H
2
O
En ies
a
Ligands Time (h) Yield
b
(%) ee
c
(%)
1L1 24 60 58
2L2 24 44 47
3L3 24 48 45
4L4 24 58 48
5L5 24 45 44
a
Reac ions we e pe o med on 0.2 mmol o isa in and 10.0 mmol o
ace one.
b
Isola ed yields ae column pu ica ion.
c
Enan iome ic
excess (ee) was de e mined by chi al HPLC using a Daicel Chi alpak
AD-H (25 cm 4.6 mm 5mm).
Table 3 Enan ioselec i i y Aldol eac ion o 5-b omoisa in (1a) wi h
ace one (2a); sol en s and me al sal sc eening
En ies
a
Sol en s Me al sal s Time (h) Yield
b
(%) ee
c
(%)
1 E OH Cu(OAc)
2
$H
2
O24 60 58
2CH
2
Cl
2
Cu(OAc)
2
$H
2
O24 58 74
3 Dioxane Cu(OAc)
2
$H
2
O24 45 76
4THF Cu(OAc)
2
$H
2
O24 65 82
5 THF Zn(OT )
2
72 T ace —
6 THF Zn(OAc)
2
$2H
2
O72 50 17
7 THF Mg(OT )
2
72 ——
8 THF Yb(OT )
3
72 ——
9 THF E (OT )
3
72 ——
a
Reac ions we e pe o med on 0.2 mmol o isa in and 10.0 mmol o
ace one.
b
Isola ed yields ae column pu ica ion.
c
Enan iome ic
excess (ee) was de e mined by chi al HPLC using a Daicel Chi alpak
AD-H (25 cm 4.6 mm 5mm).
© 2022 The Au ho (s). Published by he Royal Socie y o Chemis y RSC Ad ., 2022, 12,6149–6165 | 6151
Pape RSC Ad ances
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
able o affo d be e yield and enan ioselec i i y o he asym-
me ic Aldol eac ion o 5-b omoisa in (1a) wi h ace one (2a,50
eq.). Howe e , u he op imiza ions a e equi ed as he esul s
we e no up o he ma ks as a as yields and enan ioselec ios
a e conce ned. The e o e, o he c ucial pa ame e s such as
loading o ca alys , equi alen o ace one, ime a ia ion and
empe a u e con ol we e u he sc eened o ob ain he bes
op imized condi ion o he asymme ic Aldol eac ion.
To nd ou he bes op imized pa ame e s, ini ially Aldol
eac ion we e pe o med using 5 mol% and 15 mol% o ligand
L1 wi h 20 mol% o Cu(OAc)
2
$H
2
O in THF a o 24 h and i
can be seen om he esul s ha nei he he yields (52% & 68%)
no enan ioselec i i ies (74% & 70% ee) we e imp o ed (Table 4,
en ies 1 & 2). Then he loading o Cu(OAc)
2
$H
2
O as me al sal
we e inc eased om 20 o 30 and 40 mol%, keeping he o he
pa ame e s unchanged (10 mol% o ligand L1 in THF a o 24
h). We obse ed ha , bo h he co esponding yields (88% and
88%) as well as enan iome ic excess (96% & 86% ee) we e
imp o ed signican ly (Table 4, en ies 3 & 4), al hough
10 : 30 mol% a io o L1-Cu(OAc)
2
$H
2
O was ound o be he bes
choice o he asymme ic Aldol eac ion as i has u nished he
nal p oduc 3a in excellen yield and enan ioselec i i y (88%
yield, 96% ee) (Table 4, en y 3). Nex , may be he empe a u e
has an impac on ca aly ic efficiency o his new ca aly ic
sys em. The e o e, he eac ion was u he pe o med, using
10 : 30 mol% o L1-Cu(OAc)
2
$H
2
O in THF a o 24 h a lowe
empe a u e 10 C as well as 0 C, bu un o una ely esul s
indica ed ha , he yields (69% & 53%) and enan ioselec i i ies
(73%, 71% ee) bo h we e signican ly d opped (Table 4, en ies
5 & 6) al hough p olong eac ion ime (48 h) was gi en. We
u he in es iga ed he eac ion wi h diffe en mola a io o
ace one (10, 20, 40, 60 eq.) unde he bes op imum pa ame e s
and he ndings a e epo ed in Table 4 en ies 7–10, s ill 50 eq.
o ace one is he bes choice o ge be e yield and
enan ioselec i i y. F om he o e all in es iga ion, we came o
conclusion ha , 10 mol% o ligand L1 wi h 30 mol% o
Cu(OAc)
2
$H
2
O in THF a o 24 h p oduced bes esul as we
ob ained aldol p oduc in high yield (88%) and enan iose-
lec i i y (96%).
Ae es ablishing s anda d eac ion pa ame e s, we
ex ended he subs a e scope o he asymme ic Aldol eac ion
unde he op imized eac ion condi ion, using Lewis acid
ca alys L1-Cu(OAc)
2
$H
2
O (10 : 30 mol%) in THF a o 24 h. A
a ie y o subs i u ed isa in (1a–l) wi h se e al ace one de i a-
i es (2a–h) we e sc eened o he asymme ic Aldol eac ion
using op imized eac ion pa ame e and he co esponding
aldol chi al de i a i es o 3-hyd oxyindolin-2-one (3a–s) we e
ob ained in good o excellen yields (81–99%) wi h mode a e o
high enan iome ic excess (35–96% ee) and he esul s a e
summa ized in Table 5. Ou op imized ca aly ic sys em wo ked
efficien ly in case o isa in de i a i es bea ing elec on-dona ing
g oups (5-Me and N-Me) which affo ded aldol p oduc s 3h (99%
yield, 93% ee) and 3j (91% yield, 89% ee) espec i ely (Table 5,
en ies 8 & 10). Excep ionally, 5-b omoisa in affo ded bes
enan ioselec i i y (96% ee) and good yield (88%) (Table 5, en y
1). While, in case o isa in de i a i es con aining elec on-
wi hd awing g oups such as 5-Cl, N-benzyl and N-e hyl-
b omide, his ca aly ic sys em also wo ked ema kable well and
affo ded espec i e aldol p oduc s (3c,3k and 3l) wi h excellen
yields (99%, 91% and 98%) and e y good enan iome ic excess
(76%, 78% and 71% ee) (Table 5, en ies 3, 11 & 12). Howe e ,
his ca aly ic sys em u nished aldol p oduc s 3b,3e,3 and 3i
wi h e y good yields (99%, 99%, 88% and 97%) and mode a e
enan ioselec i i ies (62%, 55%, 44% and 53% ee) when isa in, 5-
me hoxy, 5-ni o and 5-uo o isa in we e used as nucleophilic
cen e o Aldol eac ion (Table 5, en ies 2, 5, 6 & 9). No ewo hy
o men ion ha , while using 6-chlo o and 5,7-dib omo isa in o
he Aldol eac ion, ou ca aly ic sys em pe o med unde
Table 4 Enan ioselec i e Aldol eac ion o 5-b omoisa in (1a) wi h ace one (2a); loading o ca alys and empe a u e con ol
#
a
L1/Cu(OAc)
2
$H
2
O
(mol%) Ace one (eq.) Time (h) Temp (
o
C) Yield
b
(%) ee
c
(%)
1 05/20 50 24 25 52 74
2 15/20 50 24 25 68 70
310/30 50 24 25 88 96
4 10/40 50 24 25 88 86
5 10/30 50 48 10 69 73
6 10/30 50 48 0 53 71
7 10/30 10 24 25 65 82
8 10/30 20 24 25 72 85
9 10/30 40 24 25 79 86
10 10/30 60 24 25 74 85
a
Reac ions we e pe o med on a 0.2 mmol o isa in and 10–60 eq. o ace one.
b
Isola ed yields ae column pu ica ion.
c
Enan iome ic excess (ee)
was de e mined by chi al HPLC using a Daicel Chi alpak AD-H (25 cm 4.6 mm 5mm).
6152 |RSC Ad ., 2022, 12,6149–6165 © 2022 The Au ho (s). Published by he Royal Socie y o Chemis y
RSC Ad ances Pape
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
Table 5 L1-Cu(OAc)
2
$H
2
O ca alyzed asymme ic Aldol eac ion o subs i u ed isa in (1a–l) wi h ke one (2a–h) unde op imized eac ion
pa ame e s. P oposed ansi ion s a es o he final compound
En ies
a
R
1
R
2
R
3
(2a–g)3a–sTime [h] Yield
b
[%] ee
c
[%] Abs. con .
d
1 5-B H CH
3
3a 24 88 96 (S)
d67
2HHCH
3
3b 30 99 62 (S)
d67
3 5-Cl H CH
3
3c 30 99 76 (S)
d67
4 6-Cl H CH
3
3d 30 99 35 (S)
d
5 5-OMe H CH
3
3e 30 99 55 (S)
d67
6 5-NO
2
HCH
3
3 30 88 44 (S)
d67
7 5,7-B H CH
3
3g 30 90 36 (S)
d67,78
8 5-CH
3
HCH
3
3h 35 99 93 (S)
d67
9 5-F H CH
3
3i 35 97 53 (S)
d67
10 H CH
3
CH
3
3j 38 91 89 (S)
d67,78
11 H Bn CH
3
3k 38 98 78 (S)
d67
12 H C
2
H
4
–B CH
3
3l 35 99 71 (S)
d
13 5-B H Ph 3m 15 93 77 (S)
d
14 5-B H 2-NO
2
Ph 3n 15 96 70 (S)
d
15 5-B H 4-FPh 3o 15 93 81 (S)
d
16 5-B H 4-B Ph 3p 15 92 81 (S)
d
17 5-B H 4-NO
2
Ph 3q 15 88 54 (S)
d
© 2022 The Au ho (s). Published by he Royal Socie y o Chemis y RSC Ad ., 2022, 12,6149–6165 | 6153
Pape RSC Ad ances
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
expec a ion in inducing chi ali y in he aldol p oduc s and
affo ded 3d and 3g wi h poo enan ioselec i i ies (35% & 36%
ee), howe e quan i a i e chemical yields we e ob ained (99% &
90%) (Table 5, en ies 4 & 7).
In iew o he abo e ndings, we u he in es iga ed he
efficiency o ou bes ca aly ic sys em L1-Cu(II) as a Lewis acid
ca alys unde he op imized eac ion pa ame e s. Subse-
quen ly, he asymme ic Aldol eac ion o 5-b omo isa in (1a)
wi h subs i u ed ace one (2b–e,2h) we e ca ied ou and he
co esponding aldol p oduc 3m–pand 3s we e ob ained in
excellen yields (93%, 96%, 93%, 92% and 99%) wi h e y good
enan iome ic excess (77%, 70%, 81%, 81% and 85% ee) (Table
5, en ies 13–16, 19). Howe e , aldol p oduc 3q and 3 we e
u nished in good yields (88% and 81%) wi h mode a e enan-
iome ic excess (54% and 50% ee) while using p-ni o and p-
hyd oxy ace ophenone (2 ,2g) as subs a e o he Aldol eac ion
unde op imized eac ion condi ions o 15 h and he ndings
a e epo ed in Table 5, en ies 13–19.
Table 5 (Con d. )
En ies
a
R
1
R
2
R
3
(2a–g)3a–sTime [h] Yield
b
[%] ee
c
[%] Abs. con .
d
18 5-B H 4-OHPh 3 15 81 50 (S)
d
19 5-B H Cyclohexanone 3s 35 99 85 (S,R)
d72
a
Reac ions we e pe o med on a 0.2 mmol o isa in and 10.0 mmol o ace one o cyclohexanone in 2 mL o THF.
b
Isola ed yields ae column
pu ica ion.
c
Enan iome ic excess (ee) was de e mined by chi al HPLC using a Daicel Chi alpak AD-H/OD-H column (25 cm 4.6 mm 5
mm).
d
Absolu e congu a ions we e de e mined by c ys al s uc u e and e en ion ime ma ched wi h he li e a u e.
6154 |RSC Ad ., 2022, 12,6149–6165 © 2022 The Au ho (s). Published by he Royal Socie y o Chemis y
RSC Ad ances Pape
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
No ewo hy o men ion ha , he (S)-enan iome elu ed as e
han (R)-enan iome in he HPLC ch oma og am o aldol
p oduc 3a–c,3e–l, while o he N-subs i u ed aldol p oduc 3j,
3k and 3l, e e se ends we e ollowed, hose a e epo ed in
he li e a u e.
67,78
Fo aldol p oduc 3s, e en ion ime o syn-
majo /mino and an i-majo /mino we e well ma ched wi h
he da a a ailable in he li e a u e.
72
The e o e, all he aldol
p oduc s a e p edominan ly ound o be en iched wi h (S)-
enan iome as hei e en ion ime and op ical o a ions we e
absolu ely in ag eemen wi h he li e a u e da a.
67,78
The abso-
lu e congu a ion o compound 3 was u he unambiguously
con med by single-c ys al X- ay analysis (CCDC numbe -
2143162, see ESI†S-64). In case o aldol p oduc s 3m– he
absolu e congu a ions we e also assigned as (S)-enan iome ,
assuming ha he eac ion ook place by ollowing uni o m
mechanis ic pa hway (Fig. 3).
Ca aly ic asymme ic s udies o Domino Knoe enagel Michael
cycliza ion
To illus a e he gene ali y o ca aly ic asymme ic applica ion
o ou Lewis acid ca aly ic sys em (10 : 30 mol% o L1-Cu(II)in
THF a oom empe a u e o 5–15 h), we ex ended he eac ion
scope and he e o e ca aly ic asymme ic Domino Knoe enagel
Michael cycliza ion eac ions we e pe o med using he same
op imized pa ame e s and he summa y o he ndings a e
documen ed in Table 6. F om he esul s o Domino Knoe e-
nagel Michael eac ion, i can be clea ly obse ed ha he
subs i u ed isa ins (1a–l) eac ed e y well wi h malononi ile (4)
and e hylace oace a e (5) in o de o u nished ano he se o
biologically impo an oxindoles de i a i es (6a–l) in excellen
yields (89–99%) and mode a e o high enan iome ic excess (24–
95% ee), hose cons i u es o spi o[4H-py an-3,30-oxindole]
mo i used wi h 2-aminopy ans he e ocyclic ing. I can be
Fig. 3 P oposed mechanism o Lewis acid ca alysis o asymme ic Aldol condensa ion eac ion.
© 2022 The Au ho (s). Published by he Royal Socie y o Chemis y RSC Ad ., 2022, 12,6149–6165 | 6155
Pape RSC Ad ances
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
no iced ha his ca aly ic sys em p oduced bes yields (98%,
93% & 97%) and enan iome ic excess (91%, 87% & 95% ee)
when 5-b omo, 5-me hoxy and 5-me hyl isa ins we e subse-
quen ly used as subs a e (Table 5, en ies 1, 5 & 8); while in case
o 5-ni o and N-benzyl isa ins, ou ca aly ic sys em L1-
Cu(OAc)
2
$H
2
O a e also ound o be qui e capable o inducing
p e y good chi ali y (80% & 81% ee) wi h high yields (89% &
98%) acco dingly (Table 6, en ies 6 & 11). In case o isa in and
i s de i a i es such as 5-Cl, 6-Cl, 5,7-dib omo, 5-F and N-Me
isa ins, he ca alys L1-Cu(OAc)
2
$H
2
O pe o med e y well in
e ms o chemical yields (92–99%) o p oduce co esponding
spi o[4H-py an-3,30-oxindole] de i a i es 6b–d,6g,6i and 6j
wi h mode a e enan ioselec i i ies (41.7%, 57.1%, 47%, 50%,
39%, 63% ee) (Table 6, en ies 2–4, 7, 9 & 10). Ne e heless, his
ca aly ic sys em pe o med poo ly in p omp ing chi al induc-
ion when N-e hylb omide isa in was used as subs a e pe haps
due o he s e ic hind ance caused by he wo long chain o N-
e hylb omide o subs a e (1l) and enol-es e (5) (Fig. 4) and he
a e o eac ion is compa a i ely high as i has aken 5 h only
(89% yield, 24% ee). Howe e chemical con e sion is e y good
(Table 6, en y 12). All he Domino Knoe enagel Michael p od-
uc s a e ound o be en iched wi h (S)-enan iome
p edominan ly.
(R)-enan iome elu ed as e han (S)-enan iome in he
HPLC ch oma og am o Domino Knoe enagel Michael cyclized
spi o-oxindole p oduc s 6a–c,6e,6h and 6i, while o he N-
subs i u ed spi o-oxindole 6j,6k and 6l, e e se ends we e
ollowed, hose a e well epo ed in he li e a u e.
97
All he spi o-
oxindole p oduc s a e p edominan ly ound o be en iched wi h
(S)-enan iome as hei e en ion ime and op ical o a ion we e
well in ag eemen wi h he li e a u e da a.
97
The absolu e
congu a ion o spi o-oxindole p oduc s 6d,6 and 6g we e
also assigned as (S)-enan iome as hei e en ion ime ollowed
he simila ends as o compound 6a–c, assuming ha he
eac ion ook place by ollowing uni o m mechanis ic pa hway
(Fig. 4).
Expe imen al
Gene al
All he chemicals (isa in, de i a i es o isa in, ace one, ace one
de i a i es, me al sal s) and sol en s we e pu chased om
Sigma-Ald ich and used as ecei ed. Thiophene-2,5-bis(b-
amino-alcohol) ligands (L1–L5) we e eshly syn hesized om
comme cially a ailable hiophene-2,5-dica baldehyde and
chi al b-amino alcohols in a well d ied ask unde a s a ic
p essu e o ni ogen. S anda d p ocedu es we e ollowed o
sol en s d ying be o e usage. Reac ions we e moni o ed by hin
laye ch oma og aphy using Me ck silica gel 60 Kieselgel F254
TLC (Me ck, Kenilwo h, NJ, USA) and column ch oma og aphy
was pe o med on silica gel 100–200 (40–63 mm, ASTM) om
Me ck using he p ope sol en s.
1
H and
13
C-NMR spec a we e
eco ded in CDCl
3
and DMSO-d
6
on a Jeol Spec ome e (Jeol,
Tokyo, Japan) (500 MHz). The chemical shis a e epo ed
in ppm. All he acemic p oduc s we e eshly p epa ed as pe
Table 6 L1-Cu(OAc)
2
$H
2
O ca alyzed asymme ic h ee componen s one po syn hesis o spi ooxindole using subs i u ed isa in (1a–l), malo-
noni ile (4) and e hylace oace a e (5) unde op imized eac ion pa ame e s
En y
a
R
1
R
2
6a–lTime [h] Yield
b
[%] ee
c
[%] Abs. con .
d
1 5-B H 6a 15 98 91 (S)
97
2H H 6b 13 99 42 (S)
97
3 5-Cl H 6c 89657(S)
97
4 6-Cl H 6d 15 92 47 (S)
5 5-OCH
3
H6e 15 93 87 (S)
97
6 5-NO
2
H6 15 89 80 (S)
7 5,7-B H 6g 15 96 50 (S)
8 5-CH
3
H6h 15 97 95 (S)
97
9 5-F H 6i 15 98 39 (S)
97
10 H CH
3
6j 15 99 63 (S)
97
11 H Bn 6k 15 98 81 (S)
95,97
12 H C
2
H
4
–B 6l 58924(S)
a
Reac ions we pe o med on a 0.2 mmol o isa in in 2 mL o THF.
b
Isola ed yields ae column pu ica ion.
c
Enan iome ic excess (ee) was
de e mined by chi al HPLC using a Daicel Chi alpak AD-H column (25 cm 4.6 mm 5mm).
d
Absolu e congu a ions we e de e mined by
c ys al s uc u e and e en ion ime ma ched wi h he li e a u e.
6156 |RSC Ad ., 2022, 12,6149–6165 © 2022 The Au ho (s). Published by he Royal Socie y o Chemis y
RSC Ad ances Pape
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
CH
3
OH); [ e . 97 [a]
24
D
¼+20.4(c1.0, MeOH)];
1
H-NMR (500
MHz, DMSO-d
6
): d(ppm) ¼7.48–7.45 (m, 2H, A –H), 7.33–7.30
(m, 2H, A –H), 7.28 (s, 1H, A –H), 7.25 (s, 2H, NH
2
), 7.20 ( d, J¼
7.7, 1.3 Hz, 1H, A –H), 7.15 (dd, J¼7.4, 1.3 Hz, 1H, A –H), 7.00
( d, J¼7.5, 1.0 Hz, 1H, A –H), 6.86 (d, J¼7.7 Hz, 1H, A –H), 5.00
(d, J¼15.8 Hz, 1H, CH
2(a)
Bn), 4.78 (d, J¼15.8 Hz, 1H,
CH
2(b)
Bn), 3.78 (q, J¼7.1 Hz, 1H, CH
2
CH
3
), 3.52 (dd, J¼10.8,
7.1 Hz, 1H, CH
2
CH
3
), 2.34 (s, 3H, CH
3
), 0.58 ( , J¼7.1 Hz, 3H,
CH
2
CH
3
);
13
C-NMR (126 MHz, DMSO-d
6
): d(ppm) ¼177.20,
164.38, 159.19, 158.86, 142.77, 136.19, 133.65, 128.40, 127.55,
123.34, 122.73, 117.57, 108.91, 104.55, 60.11, 56.12, 48.52,
43.39, 18.65, 13.08. All he analy ical da a a e well in ag eemen
wi h he epo ed li e a u e.
97
E hyl-(S)-20-amino-1-(2-b omoe hyl)-30-cyano-60-me hyl-2-oxo-
spi o[indoline-3,40-py an]-50-ca boxyla e (6l). 1-(2-B omoe hyl)
isa in 1l (50.8 mg, 0.2 mmol), malononi ile 4(13.2 mg, 0.2
mmol) and e hylace oace a e 5 (26.0 mg, 0.2 mmol) we e eac ed
acco ding o he GP2 o yield p oduc 6l as whi e solid; m.p.:
148–150 C; isola ed yield (76.9 mg, 89%). Enan iome ic excess
(ee) was de e mined by chi al HPLC [Daicel Chi alpak AD-H
column], 85.0% n-hexane/i-P OH, 1.0 mL min
1
;
majo
¼
15.03 min;
mino
¼24.53 min; l¼254 nm; 23% ee; [a]
20
D
¼
+5.34(c0.10, CH
3
OH); IR (KB ): 3382, 2924, 2854, 2191, 1709,
1682, 1613, 1599, 1486, 1466, 1419, 1380, 1348, 1282, 1253,
1211, 1149, 1077, 756, 682 cm
1
;
1
H-NMR (500 MHz, DMSO-d
6
):
d(ppm) ¼7.29 ( d, J¼7.6, 1.3 Hz, 1H, A –H), 7.23 (s, 2H, NH
2
),
7.18–7.13 (m, 2H, A –H), 7.03 ( d, J¼7.5, 1.0 Hz, 1H, A –H), 4.16
(ddd, J¼14.2, 7.7, 6.5 Hz, 1H, CH
3
CH
2(a)
), 4.03 (ddd, J¼14.2,
7.7, 6.1 Hz, 1H, CH
3
CH
2(b)
), 3.82 (dq, J¼11.0, 7.1 Hz, 1H,
NCH
2(a)
), 3.72 (qd, J¼7.1, 4.6 Hz, 1H, NCH
2(b)
), 3.63–3.57 (m,
2H, CH
2
B ), 2.33 (s, 3H, CH
3
), 0.71 ( , J¼7.1 Hz, 3H, CH
2
CH
3
);
13
C-NMR (126 MHz, DMSO-d
6
): d(ppm) ¼177.03, 164.32,
158.99, 142.18, 133.54, 128.76, 123.41, 122.84, 117.14, 108.70,
104.36, 60.25, 56.08, 48.41, 41.57, 28.36, 18.67, 13.22.
Conclusions
In summa y, we ha e de eloped e y efficien enan ioselec i e
p ocess o he asymme ic Aldol eac ion o subs i u ed isa in
wi h se e al ace one de i a i es using L1-Cu(II) as a new Lewis
acid ca alys based on hiophene-2,5-bis(amino-alcohol)
amewo k. Ou Lewis acid ca aly ic sys em L1-Cu(II) ac s b il-
lian ly and u nished aldol p oduc s 3a–sin high yields and
selec i i y (up o 99% yield; up o 96% ee). This ca aly ic sys em
L1-Cu(OAc)
2
$H
2
O was u he u ilized o asymme ic Domino
Knoe enagel Michael cycliza ion eac ion o subs i u ed isa in
wi h malononi ile and e hylace oace a e and affo ded chi al
spi o[4H-py an-3,3-oxindole] de i a i es 6a–lwi h high yields
and mode a e o high enan ioselec i i ies (up o 99% yield; up
o 95% ee). Bo h he eac ions we e pe o med unde mild
eac ion condi ion a oom empe a u e.
Au ho con ibu ions
Concep ualiza ion, A. M. A.-M. and A. B.; supe ision, A. M. A.-
M., A. B. and M. S. I; me hodology, A. S. A., M. S. I. and A. M. A.-
M.; alida ion, M. S. I., A. S. A., S. A. and A. M. A.-M.; o mal
analysis, A. S. A.; M. S. I. and S. A.; in es iga ion, A. S. A.; M. S. I.
and S. A.; esou ces, A. M. A.-M. and A. B.; da a cu a ion, A. S.
A., M. S. I., and A. B.; w i ing—o iginal d ap epa a ion, M. S.
I., A. B. and A. S. A.; w i ing— e iew and edi ing, M. S. I., A. B.
and A. M. A.-M.; isualiza ion, A. B., M. S. I and S. A.; p ojec
adminis a ion, A. M. A.-M. and A. B.; unding acquisi ion, A. M.
A.-M. and A. B.; sowa e A. S. A., M. S. I., M. A. and A. B.; all
au ho s ha e ead and ag eed o he published e sion o he
manusc ip .
Conflic s o in e es
The e a e no conic s o decla e.
Acknowledgemen s
The au ho s would like o ex end hei since e app ecia ion o
he Resea che s Suppo ing P ojec (RSP2022R427), King Saud
Uni e si y, Riyadh, Saudi A abia.
No es and e e ences
1 P. W. V. Leeuwen, P. C. Kame , C. Cla e , O. Pamies and
M. Dieguez, Chem. Re ., 2011, 111, 2077–2118.
2 A. Ba aka , M. S. Islam, A. M. Al Majid and Z. A. Al-O hman,
Te ahed on, 2013, 69, 5185–5192.
3 M. S. Islam, A. M. Al Majid, Z. A. Al-O hman and A. Ba aka ,
Te ahed on: Asymme y, 2014, 25, 245–251.
4 M. S. Islam, A. S. Alamma i, A. Ba aka , S. Alshah ani,
M. Haukka and A. M. Al-Majid, Molecules, 2021, 26, 7408.
5 A. S. Alamma i, A. M. Al-Majid, A. Ba aka , S. Alshah ani,
M. Ali and M. S. Islam, Ca alys s, 2021, 11, 1208.
6 T. Mukaiyama, O g. Reac ., 1982.
7 Q. Guo, M. Bhanushali and C. G. Zhao, Angew. Chem., In .
Ed., 2010, 49, 9460–9464.
8 T. Yan, X. Wang, H. Sun, J. Liu and Y. Xie, Molecules, 2013,
18, 14505–14518.
9 V. Kuma , K. Kau , G. K. Gup a and A. K. Sha ma, Eu . J.
Med. Chem., 2013, 69, 735–753.
10 V. Raj, In . J. Cu . Pha m. Res., 2012, 4,1–9.
11 C. Ma i and E. M. Ca ei a, Eu . J. O g. Chem., 2003, 2003,
2209–2219.
12 C. V. Galli o d and K. A. Scheid , Angew. Chem., In . Ed.,
2007, 46, 8748–8758.
13 S. Peddibho la, Cu . Bioac . Compd., 2009, 5,20–38.
14 S. Mohammadi, R. Hei an, R. P. He e a and E. Ma ques-
Lopez, ChemCa Chem, 2013, 5, 2131–2148.
15 R. B. Lab oo and L. A. Cohen, J. O g. Chem., 1990, 55, 4901–
4904.
16 P. Hewawasam, N. A. Meanwell, V. K. G ibkoff,
S. I. Dwo e zky and C. G. Boissa d, Bioo g. Med. Chem.
Le ., 1997, 7, 1255–1260.
17 Y. Q. Tang, I. Sa le , R. Thie icke, S. G abley and X. Z. Feng,
Eu . J. O g. Chem., 2001, 2001, 261–267.
18 T. Tokunaga, W. E. Hume, T. Umezome, K. Okazaki,
Y. Ueki, K. Kumagai, S. Hou ai, J. Nagamine, H. Seki and
M. Taiji, J. Med. Chem., 2001, 44, 4641–4649.
© 2022 The Au ho (s). Published by he Royal Socie y o Chemis y RSC Ad ., 2022, 12,6149–6165 | 6163
Pape RSC Ad ances
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
19 P. Hewawasam, M. E way, S. L. Moon, J. Knipe, H. Weine ,
C. G. Boissa d, D. J. Pos -Munson, Q. Gao, S. Huang and
V. K. G ibkoff,J. Med. Chem., 2002, 45, 1487–1499.
20 V. Khuzhae , I. Zhalolo , K. Tu guno , B. Tashkhodzhae ,
M. Le ko ich, S. A ipo a and A. Shashko , Chem. Na .
Compd., 2004, 40, 269–272.
21 H. B. Rasmussen and J. K. MacLeod, J. Na . P od., 1997, 60,
1152–1154.
22 T. Kaga a, S. Sai o, H. Shigemo i, A. Ohsaki, H. Ishiyama,
T. Kubo a and J. i. Kobayashi, J. Na . P od., 2006, 69,
1517–1521.
23 Y. Kamano, H.-p. Zhang, Y. Ichiha a, H. Kizu, K. Komiyama
and G. R. Pe i , Te ahed on Le ., 1995, 36, 2783–2784.
24 C. Moody, I. Richa ds and A. Z. Slawin, J. Chem. Soc., Pe kin
T ans. 1, 1997, 2405–2412.
25 T. Nakamu a, S.-i. Shi okawa, S. Hosokawa, A. Nakazaki
and S. Kobayashi, O g. Le ., 2006, 8, 677–679.
26 S. Nakamu a, N. Ha a, H. Nakashima, K. Kubo, N. Shiba a
and T. To u, Chem.–Eu . J., 2008, 14, 8079–8081.
27 G. Luppi, M. Mona i, R. J. Co ˆ
ea, F. d. A. Violan e,
A. C. Pin o, B. Kap ein, Q. B. B ox e man, S. J. Ga den
and C. Tomasini, Te ahed on, 2006, 62, 12017–12024.
28 J. S. Ca le and C. Ch is ophe sen, J. O g. Chem., 1981, 46,
3440–3443.
29 K. Nicolaou, X. Huang, N. Giuseppone, P. Bheema Rao,
M. Bella, M. V. Reddy and S. A. Snyde , Angew. Chem., In .
Ed., 2001, 40, 4705–4709.
30 K. Nicolaou, M. Bella, D. Y. K. Chen, X. Huang, T. Ling and
S. A. Snyde , Angew. Chem., In . Ed., 2002, 114, 3645–3649.
31 K. Nicolaou, P. Bheema Rao, J. Hao, M. V. Reddy, G. Rassias,
X. Huang, D. Y. K. Chen and S. A. Snyde , Angew. Chem., In .
Ed., 2003, 42, 1753–1758.
32 K. Nicolaou, S. A. Snyde , N. Giuseppone, X. Huang,
M. Bella, M. V. Reddy, P. B. Rao, A. E. Koumbis,
P. Giannakakou and A. O'B a e, J. Am. Chem. Soc., 2004,
126, 10174–10182.
33 K. Nicolaou, D. Y.-K. Chen, X. Huang, T. Ling, M. Bella and
S. A. Snyde , J. Am. Chem. Soc., 2004, 126, 12888–12896.
34 C. Takahashi, A. Numa a, Y. I o, E. Ma sumu a, H. A aki,
H. Iwaki and K. Kushida, J. Chem. Soc., Pe kin T ans. 1,
1994, 1859–1864.
35 A. F ´
echa d, N. Fab e, C. P´
ean, S. Mon au , M.-T. Fau el,
P. Rollin and I. Fou as ´
e, Te ahed on Le ., 2001, 42,
9015–9017.
36 M. Ki ajima, I. Mo i, K. A ai, N. Kogu e and H. Takayama,
Te ahed on Le ., 2006, 47, 3199–3202.
37 J. I. Jimenez, U. Hube , R. E. Moo e and G. M. Pa e son, J.
Na . P od., 1999, 62, 569–572.
38 B. K. Alb ech and R. M. Williams, O g. Le ., 2003, 5, 197–
200.
39 S. Lin, Z.-Q. Yang, B. H. Kwok, M. Koldobskiy, C. M. C ews
and S. J. Danishe sky, J. Am. Chem. Soc., 2004, 126, 6347–
6355.
40 K. S. Feldman and A. G. Ka a jas, O g. Le ., 2004, 6, 2849–
2852.
41 H. Suzuki, H. Mo i a, M. Shi o and J. i. Kobayashi,
Te ahed on, 2004, 60, 2489–2495.
42 M. Such´
y, P. Ku schy, K. Monde, H. Go o, N. Ha ada,
M. Takasugi, M. Dzu illa and E. Balen o a, J. O g. Chem.,
2001, 66, 3940–3947.
43 F. Zhou, Y. L. Liu and J. Zhou, Ad . Syn h. Ca al., 2010, 352,
1381–1407.
44 J. J. Badillo, N. V. Hanhan and A. K. F anz, Cu . Opin. D ug
Disco e y De ., 2010, 13, 758–776.
45 A. Kuma and S. S. Chimni, RSC Ad ., 2012, 2, 9748–9762.
46 B. Alcaide and P. Almend os, Angew. Chem., In . Ed., 2003,
42, 858–860.
47 B. Lis , L. Hoang and H. J. Ma in, P oc. Na l. Acad. Sci. U. S.
A., 2004, 101, 5839–5842.
48 C. Allemann, R. Go dillo, F. R. Clemen e, P. H.-Y. Cheong
and K. Houk, Acc. Chem. Res., 2004, 37, 558–569.
49 S. Sai o and H. Yamamo o, Acc. Chem. Res., 2004, 37, 570–
579.
50 S. M. Dean, W. A. G eenbe g and C. H. Wong, Ad . Syn h.
Ca al., 2007, 349, 1308–1320.
51 M. Raj and V. K. Singh, Chem. Commun., 2009, 6687–6703.
52 V. Bisai, A. Bisai and V. K. Singh, Te ahed on, 2012, 68,
4541–4580.
53 B. Lis , R. A. Le ne and C. F. Ba bas, J. Am. Chem. Soc.,
2000, 122, 2395–2396.
54 A. Spek, Ac a C ys allog ., Sec . D: Biol. C ys allog ., 2009, 65,
148–155.
55 G. Luppi, P. G. Cozzi, M. Mona i, B. Kap ein,
Q. B. B ox e man and C. Tomasini, J. O g. Chem., 2005,
70, 7418–7421.
56 E. M. Beccalli, A. Ma chesini and T. Pila i, J. Chem. Soc.,
Pe kin T ans. 1, 1994, 579–587.
57 S. J. Ga den, R. B. da Sil a and A. C. Pin o, Te ahed on,
2002, 58, 8399–8412.
58 T. Kawasaki, M. Nagaoka, T. Sa oh, A. Okamo o, R. Ukon
and A. Ogawa, Te ahed on, 2004, 60, 3493–3503.
59 W.-B. Chen, Y.-H. Liao, X.-L. Du, X.-M. Zhang and
W.-C. Yuan, G een Chem., 2009, 11, 1465–1476.
60 R. J. Co ˆ
ea, S. J. Ga den, G. Angelici and C. Tomasini, Eu .
J. O g. Chem., 2008, 2008, 736–744.
61 G. Angelici, R. J. Co ˆ
ea, S. J. Ga den and C. Tomasini,
Te ahed on Le ., 2009, 50, 814–817.
62 J. G. He n´
andez, V. Ga c´
ıa-L´
opez and E. Jua is i,
Te ahed on, 2012, 68,92–97.
63 M. Kinsella, P. G. Duggan and C. M. Lennon, Te ahed on:
Asymme y, 2011, 22, 1423–1433.
64 J.-R. Chen, X.-P. Liu, X.-Y. Zhu, L. Li, Y.-F. Qiao, J.-M. Zhang
and W.-J. Xiao, Te ahed on, 2007, 63, 10437–10444.
65 C. Shen, F. Shen, H. Xia, P. Zhang and X. Chen, Te ahed on:
Asymme y, 2011, 22, 708–712.
66 T. P. Kuma , N. Manjula and K. Ka agun a, Te ahed on:
Asymme y, 2015, 26, 1281–1284.
67 G. D. Yada and S. Singh, Te ahed on: Asymme y, 2016, 27,
123–129.
68 A. J. Pea son and S. Panda, O g. Le ., 2011, 13, 5548–5551.
69 G. D. Yada and S. Singh, Te ahed on: Asymme y, 2015, 26,
1156–1166.
70 N. Ha a, S. Nakamu a, N. Shiba a and T. To u, Ad . Syn h.
Ca al., 2010, 352, 1621–1624.
6164 |RSC Ad ., 2022, 12,6149–6165 © 2022 The Au ho (s). Published by he Royal Socie y o Chemis y
RSC Ad ances Pape
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online
71 N. Ha a, S. Nakamu a, N. Shiba a and T. To u, Chem.–Eu .
J., 2009, 15, 6790–6793.
72 J. Wang, Q. Liu, Q. Hao, Y. Sun, Y. Luo and H. Yang,
Chi ali y, 2015, 27, 314–319.
73 M. Raj, N. Vee asamy and V. K. Singh, Te ahed on Le .,
2010, 51, 2157–2159.
74 Q. Guo and J. C.-G. Zhao, Te ahed on Le ., 2012, 53, 1768–
1771.
75 D. Ma, L. Ren, H. Yao, W. Tian, F. Chen, J. Zhang, Y. Liu and
T. Mao, J. O hop. Res., 2013, 31, 1082–1088.
76 H. Lu, J. Bai, J. Xu, T. Yang, X. Lin, J. Li and F. Ren,
Te ahed on, 2015, 71, 2610–2615.
77 S. Abba aju and J. C. G. Zhao, Ad . Syn h. Ca al., 2014, 356,
237–241.
78 A. V. Malko , M. A. Kabesho , M. Bella, O. Kysilka,
D. A. Malyshe , K. Pluh´
aˇ
cko ´
a and P. Koˇ
co sk´
y, O g. Le .,
2007, 9, 5473–5476.
79 Z.-Q. Liu, Z.-W. Xiang, Z. Shen, Q. Wu and X.-F. Lin,
Biochimie, 2014, 101, 156–160.
80 T. I oh, H. Ishikawa and Y. Hayashi, O g. Le ., 2009, 11,
3854–3857.
81 G. Chen, Y. Ju, T. Yang, Z. Li, W. Ang, Z. Sang, J. Liu and
Y. Luo, Te ahed on: Asymme y, 2015, 26, 943–947.
82 R. Singh and R. Vince, Chem. Re ., 2012, 112, 4642–4686.
83 Y.-T. Yang, J.-F. Zhu, G. Liao, H.-J. Xu and B. Yu, Cu . Med.
Chem., 2018, 25, 2233–2244.
84 M. S. Islam, M. Ali, A. M. Al-Majid, A. S. Alama y,
S. Alshah ani, S. Yousu , M. I. Choudha y and A. Ba aka ,
Molecules, 2021, 26, 2212.
85 M. S. Islam, A. M. Al-Majid, M. Azam, V. P. Ve ma,
A. Ba aka , M. Haukka, A. A. Elgaza , A. Mi a and
F. A. Bad ia, ACS Omega, 2021, 31539–31556.
86 M. S. Islam, A. M. Al-Majid, F. F. El-Senduny, F. A. Bad ia,
A. Rahman, A. Ba aka and Y. A. Elshaie , Appl. Sci., 2020,
10, 2170.
87 M. S. Islam, A. M. Al-Majid, M. Azam, V. P akash Ve ma,
A. Ba aka , M. Haukka, L. R. Domingo, A. A. Elgaza ,
A. Mi a and F. A. Bad ia, Chemis ySelec , 2021, 6, 14039–
14053.
88 A. Ba aka , M. S. Islam, M. Ali, A. M. Al-Majid, S. Alshah ani,
A. S. Alama y, S. Yousu and M. I. Choudha y, Symme y,
2021, 13, 1426.
89 A. M. Al-Majid, M. Ali, M. S. Islam, S. Alshah ani,
A. S. Alama y, S. Yousu , M. I. Choudha y and A. Ba aka ,
Molecules, 2021, 26, 6305.
90 R. Dwo czak, H. S e k, C. K a ky and H. Junek, Chem. Be .,
1989, 122, 1323–1328.
91 S. J. Chai, Y. F. Lai, J. C. Xu, H. Zheng, Q. Zhu and
P. F. Zhang, Ad . Syn h. Ca al., 2011, 353, 371–375.
92 G. B ahmacha i and B. Bane jee, Asian J. O g. Chem., 2016,
5, 271–286.
93 D. Cheng, Y. Ishiha a, B. Tan and C. F. Ba bas III, ACS
Ca al., 2014, 4, 743–762.
94 G. M. Zia ani, R. Mo adi and N. Lashga i, Te ahed on,
2018, 74, 1323–1353.
95 W.-B. Chen, Z.-J. Wu, Q.-L. Pei, L.-F. Cun, X.-M. Zhang and
W.-C. Yuan, O g. Le ., 2010, 12, 3132–3135.
96 M. Chennapu am, I. A. Owolabi, C. Seki, Y. Okuyama,
E. Kwon, K. Uwai, M. Tokiwa, M. Takeshi a and
H. Nakano, ACS Omega, 2018, 3, 11718–11726.
97 S. Konda, S. Jakkampudi, H. D. A man and J. C.-G. Zhao,
Syn h. Commun., 2019, 49, 2971–2982.
98 S. Lee and J. F. Ha wig, J. O g. Chem., 2001, 66, 3402–3415.
99 W.-J. Hao, S.-Y. Wang and S.-J. Ji, ACS Ca al., 2013, 3, 2501–
2504.
100 A. Khala-Nezhad and S. Mohammadi, ACS Comb. Sci.,
2013, 15, 512–518.
101 A. Mondal and C. Mukhopadhyay, ACS Comb. Sci., 2015, 17,
404–408.
© 2022 The Au ho (s). Published by he Royal Socie y o Chemis y RSC Ad ., 2022, 12,6149–6165 | 6165
Pape RSC Ad ances
Open Access A icle. Published on 21 Feb ua y 2022. Downloaded on 2/22/2022 6:45:53 AM.
This a icle is licensed unde a
C ea i e Commons A ibu ion-NonComme cial 3.0 Unpo ed Licence.
View A icle Online